Rudolf Fehrmann

Rudolf Fehrmann is a Physician Scientist at the Department of Medical Oncology and the Cancer Research Center Groningen within the University of Groningen (Faculty of Medical Sciences). His work bridges clinical oncology and computational biology, focusing on integrative omics approaches to identify tumor driver alterations and translate findings to clinical practice.

• Education: MD, 1 year of Mathematics/Computer Science, MSc in Cognitive Science and Engineering
• PhD: High-dimensional data analysis for ovarian cancer phenotypes (2010)

Research interests include:

• Immune checkpoint inhibitor response prediction
• Cyclin E1 and MYC pathway interactions in cancer
• Synaptic signaling in ovarian cancer prognosis
• AI-enabled biomarker discovery
• Whole blood transcriptomics for treatment monitoring

Recent articles highlight his work in:

• Tumor-immune system interactions
• Machine learning applications in cancer
• Genomic and transcriptomic biomarkers
• Therapeutic target identification

Scientific recognition includes:

• VENI Fellowship (2015)
• Bas Mulder Award (2013)
• Mandema Grant (2012)
• Pieter de Mulder Award (2011)

Active in PhD student supervision and serves as Chair of the scientific committee for the ESMO AI and Digital Oncology Congress 2025. His research contributes to UN SDG 3 (Good Health and Well-being).